ERS bronchiectasis guidelines 2025: pharmacological treatment - Amsterdam 2025

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Management of bronchiectasis in adults

Chair(s): James D. Chalmers, Myrofora Goutaki, Chiara Premuda

Session type: Guidelines session

ERS bronchiectasis guidelines 2025: pharmacological treatment

James D. Chalmers

EVENTS HOME

Previous presentation

Next presentation

Session content

Patient testimonies

Eliza Kompatsiari

Alan Timothy

Tanja Hedberg

Replay

ERS bronchiectasis guidelines 2025: recommendations for non-pharmacological management

Stefano Aliberti

Replay

Slides

ERS bronchiectasis guidelines 2025: pharmacological treatment

James D. Chalmers

Replay

Slides

Discussion and Q&A

Amelia Shoemark

Amjad Horani

Stefano Aliberti

James D. Chalmers

Replay

Session aims

to describe the key recommendations from the European Respiratory Society (ERS) bronchiectasis guidelines 2025.

The ERS Congress 2025, Amsterdam